Connect Sign In
Performed/Reported Schedule Updates
The following tests have updates to the days of the week they are performed or the expected turnaround time for a result. Visit our Hotlines page to stay up to date with test changes, inactivations, and new tests.
| Test Name | Performed | Reported | |
|---|---|---|---|
| Kratom, Umbilical Cord, Qualitative | Wed |
8-9 days |
|
| Trichomonas vaginalis by Transcription-Mediated Amplification (TMA) | Mon, Wed, Fri |
1-4 days |
|
| Factor XIII (F13A1) V34L Variant | Mon, Thu |
2-7 days |
|
| Glucose-6-Phosphate Dehydrogenase (G6PD) 2 Mutations | Mon, Thu |
4-10 days |
|
| Trypanosoma cruzi Antibody, IgG |
Wed |
1-8 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (HMGCR) Antibody, IgG | Fri |
1-15 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Anti-Phospholipase A2 Receptor (PLA2R) Antibody, IgG by ELISA | Wed, Fri |
1-7 days |
|
| HPV Primary Screen by PCR With Reflex to Cytology | Tue-Sat |
1-5 days |
|
| Toxocara Antibodies, IgG by ELISA | Thu |
1-8 days |
|
| Drug Profile, Expanded Targeted Panel by LC-MS/MS, Urine | Mon, Fri |
1-9 days |
|
| Drug Profile, Expanded Targeted Panel by LC-MS/MS, Serum/Plasma | Mon, Fri |
1-9 days |
|
| Carbamylated Protein (CarP) Antibody, IgG | Mon, Wed, Fri |
1-4 days |
|
| Inflammatory Bowel Disease Differentiation Panel | Mon, Wed, Fri |
1-4 days |
|
| Anti-sp100 and anti-gp210 Antibodies, IgG | Thu |
1-8 days |
|
| Anti-sp100 Antibody, IgG | Thu |
1-8 days |
|
| Anti-gp210 Antibody, IgG | Thu |
1-8 days |
|
| Troponin T (cTnT) 5th Generation | Sun-Sat |
Within 24 hours |
|
| Phosphatidylserine and Prothrombin Antibodies, IgG and IgM | Wed |
1-8 days |
|
| Phosphatidylserine and Prothrombin Antibody, IgM | Wed |
1-8 days |
|
| Phosphatidylserine and Prothrombin Antibody, IgG | Wed |
1-8 days |
|
| Anti-C1q Antibody, IgG | Wed |
1-15 days |
|
| Echinococcus Antibody, IgG | Tue |
1-8 days |
|
| Chromatin Antibody, IgG | Sun, Tue, Wed, Thu, Fri |
1-4 days |
|
| F-Actin (Smooth Muscle) Antibody, IgA | Thu |
1-8 days |
|
| Prothrombin Antibody, IgG | Fri |
1-8 days |
|
| Phosphatidylserine Antibodies, IgG, IgM, and IgA | Mon, Wed, Fri |
1-4 days |
|
| Treponema pallidum Antibody by TP-PA | Sun-Sat |
1-4 days |
|
| Gastric Parietal Cell Antibody, IgG | Sun, Tue, Thu |
1-3 days |
|
| Saccharomyces cerevisiae Antibodies, IgG & IgA | Mon, Wed, Fri |
2-4 days |
|
| Entamoeba histolytica (amebiasis), Antibody, IgG | Tue |
1-8 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Alkaline Phosphatase Isoenzymes, CSF | Sun-Sat |
1-4 days |
|
| Thyroid Stimulating Hormone Receptor Antibody (TRAb) | Sun-Sat |
Within 24 hours |
|
| Antimicrobial Susceptibility - Staphylococcus | Sun-Sat |
2-5 days |
|
| Osteocalcin by Electrochemiluminescent Immunoassay | Sun-Sat |
Within 24 hours |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Neurokinin A (Substance K), Plasma | Varies |
12-15 days |
|
| Factor V, R2 Mutation Detection by PCR | Varies |
5-12 days |
|
| Beryllium Lymphocyte Proliferation, Blood | Varies |
15-20 days |
|
| Antimicrobial Level - Cycloserine, Serum or Plasma | Varies |
13-17 days |
|
| Antimicrobial Level - Rifabutin by HPLC, Serum or Plasma | Varies |
13-17 days |
|
| Antimicrobial Level - Azithromycin by HPLC, Serum or Plasma | Varies |
13-17 days |
|
| Antimicrobial Level - Streptomycin by HPLC, Serum or Plasma | Varies |
13-17 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Anti-Phospholipase A2 Receptor (PLA2R) Antibody, IgG by ELISA | Wed, Fri |
1-7 days |
|
| Basement Membrane Zone Antibody Panel | Varies |
3-9 days |
|
| Keratan Sulfate, Quantitative by LC-MS/MS, Urine | Tue |
3-10 days |
|
| Desipramine, Serum or Plasma by Tandem Mass Spectrometry | Fri |
2-8 days |
|
| Collagen Type VII Antibody, IgG by ELISA | Varies |
3-9 days |
|
| Tricyclic Antidepressants, Quantitative, Serum or Plasma | Fri |
2-8 days |
|
| Clomipramine and Metabolite, Serum or Plasma | Fri |
2-8 days |
|
| Manganese, Serum | Sun-Sat |
1-3 days |
|
| Chromium, Serum | Sun-Sat |
1-3 days |
|
| Direct Immunofluorescence, Tissue Biopsy (Cutaneous, Mucosal, Epithelial) |
Varies |
3-9 days |
|
| Bullous Pemphigoid (BP180 and BP230) Antibodies, IgG by ELISA | Varies |
3-9 days |
|
| Pemphigoid Gestationis, Complement-Fixing Basement Membrane Antibodies (Herpes Gestationis Factor) | Varies |
7-14 days |
|
| Paraneoplastic Pemphigus (Paraneoplastic Autoimmune Multiorgan Syndrome) Screening Antibodies by IIF |
Varies |
3-9 days |
|
| Pemphigoid Antibody Panel | Varies |
3-9 days |
|
| Amitriptyline and Nortriptyline, Serum or Plasma | Fri |
2-8 days |
|
| Imipramine and Desipramine, Serum or Plasma | Fri |
2-8 days |
|
| Protriptyline, SP | Fri |
2-8 days |
|
| Doxepin and Metabolite, Serum or Plasma | Fri |
2-8 days |
|
| Nortriptyline | Fri |
2-8 days |
|
| Catecholamines Fractionated, Plasma | Sun-Sat |
1-5 days |
|
| Ganglioside (GM1) Antibodies, IgG and IgM | Tue, Thu, Sat |
1-7 days |
|
| Lactate Dehydrogenase, Isoenzymes | Sun-Sat |
1-3 days |
|
| Osmolality, Urine | Sun-Sat |
1-3 days |
|
| Osmolality, Serum or Plasma | Sun-Sat |
1-3 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Prion Markers (CJD), CSF | Varies |
12-22 days |
|
| Arylsulfatase A, Leukocytes, Blood | Varies |
6-12 days |
|
| N-Methylhistamine, 24-Hour Urine | Varies |
6-12 days |
|
| Luteinizing Hormone (LH), Pediatric | Varies |
8-13 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Parathyroid Hormone (PTH) Antibody | Varies |
12-18 days |
|
| Expanded Carrier Screen by Next Generation Sequencing | Varies |
17-21 days |
|
| Expanded Carrier Screen by Next Generation Sequencing with Fragile X | Varies |
17-21 days |
|
| TP53 Somatic Mutation, Prognostic | Varies |
12-18 days |
|
| Somatostatin Quantitative, Plasma | Varies |
12-18 days |
|
| Chymotrypsin, Fecal | Varies |
8-14 days |
|
| Thyroxine Antibody | Varies |
8-14 days |
|
| Insulin-Like Growth Factor Binding Protein 1 (IGFBP-1) | Varies |
8-14 days |
|
| Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) | Varies |
12-18 days |
|
| Angiotensin II, Plasma | Varies |
8-14 days |
|
| Human Anti-Mouse Antibody (HAMA), ELISA | Varies |
12-18 days |
|
| Hairstat 5 Reflexive Panel | Varies |
4-8 days |
|
| Citric Acid, Serum or Plasma | Varies |
8-14 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Gaucher Disease (GBA) Sequencing | Varies |
14-21 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Tricyclic Antidepressants, Quantitative, Urine | Sun |
2-8 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| JC Virus Antibody by ELISA, Serum with Reflex to Inhibition Assay | Varies |
6-10 days |
|
| Herpesvirus 6 Antibody, IgM by IFA, Serum | Varies |
5-9 days |
|
| Trichinella Antibody, IgG | Varies |
6-11 days |
|
| Filaria Antibody IgG4 by ELISA, Serum | Varies |
6-11 days |
|
| Herpesvirus 6 Antibody, IgG | Varies |
5-9 days |
|
| Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, by ELISA | Varies |
6-11 days |
|
| Giardia lamblia Antibody, IgG by ELISA | Varies |
6-13 days |
|
| Giardia lamblia Antibodies Panel by ELISA | Varies |
6-13 days |
|
| Vitamin B5 (Pantothenic Acid), Serum | Varies |
6-13 days |
|
| Glutathione Total | Varies |
5-9 days |
|
| Human T-Lymphotropic Virus Types I/II DNA, Qualitative Real-Time PCR | Varies |
4-7 days |
|
| Coxsackie A Antibodies (Serotypes 2, 4, 7, 9, 10 and 16), Serum | Varies |
6-11 days |
|
| Human Placental Lactogen (HPL) | Varies |
6-13 days |
|
| Chlamydia Antibody Differentiation (Lymphogranuloma Venereum) by Microimmunofluorescence | Varies |
5-9 days |
|
| Hepatitis Delta Virus (HDV), IgM Antibody, EIA | Varies |
5-9 days |
|
| Substance P, EIA | Varies |
6-13 days |
|
| Chromosome Analysis - Breakage, Fanconi Anemia, Whole Blood | Varies |
14-22 days |
|
| Toxoplasma gondii IgG Antibody, ELISA (CSF) | Varies |
5-9 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| Immunobullous Disease Antibody Panel | Varies |
3-9 days |
|
| Epidermal Transglutaminase (eTG/TG3) Antibody, IgA by ELISA | Varies |
7-21 days |
|
| Basement Membrane Zone and Cell Surface (Epithelial) Antibodies, IgG and IgA by IIF | Varies |
3-9 days |
| Test Name | Performed | Reported | |
|---|---|---|---|
| 5-Hydroxyindoleacetic Acid (HIAA), Plasma | Varies |
5-8 days |
|
| Gastric Pepsin A, Respiratory | Varies |
6-12 days |
|
| Ustekinumab Quantitation with Antibodies, Serum | Varies |
5-8 days |
|
| Leukotriene E4, 24-Hour Urine | Varies |
6-11 days |
|
| 2,3 Dinor-11Beta-Prostaglandin F2 Alpha, Random Urine | Varies |
6-11 days |
|
| Cytochrome b5 Reductase Enzyme Activity | Varies |
6-10 days |
|
| Intact Fibroblast Growth Factor 23 (FGF23), Serum | Varies |
6-11 days |
|
| Vedolizumab Quantitation with Antibodies, Serum | Varies |
8-14 days |
|
| N-Methylhistamine, Random Urine | Varies |
7-12 days |
|
| Leukotriene E4, Random Urine | Varies |
7-12 days |
|
| 2,3 Dinor-11Beta-Prostaglandin F2 Alpha, 24-Hour Urine | Varies |
9-15 days |
|
| Toxoplasma gondii Antibody, IgA by ELISA, Serum | Varies |
5-12 days |
|
| Collagen Type II Antibody by ELISA, Serum | Varies |
8-18 days |
|
| Aminolevulinic Acid Dehydratase (ALAD), Blood | Varies |
5-11 days |
|
| Signal Recognition Particle (SRP) Antibody | Varies |
16-24 days |
